Results 201 to 210 of about 65,552 (266)

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

Molecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur, Joel Rodrigues Vitória, Manuel Saiselet, Ligia Craciun, Denis Larsimont, Anne Lefort, Frédérick Libert, Carine Maenhaut, Sabine Costagliola, Maxime Tarabichi, Mirian Romitti, Vincent Detours   +11 more
wiley   +1 more source

Editorial: Swarm neuro-robots with the bio-inspired environmental perception

Frontiers in Neurorobotics
Cheng Hu, Farshad Arvin, Nicola Bellotto, Shigang Yue, Haiyang Li   +4 more
doaj   +1 more source

Swarm-based intelligent models for developing cybersecurity frameworks with IDS. [PDF]

Sci Rep
Kumar NS, Ramakrishna V, Kamal MV, Kumar KS, Reddy VSN, Ramulu PJ.   +5 more
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Predicting and explaining poor prognosis in diabetic kidney disease using SHAP-based interpretable machine learning. [PDF]

iScience
Qian M, Li L, Cheng Y, Hou Y, Fu S, Xu Z.   +5 more
europepmc   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

A RIPK2 activity signature in prostate cancer: Modulation by RIPK2 inhibition and clinical association. [PDF]

Transl Oncol
Elgehama AM, Yang Q, Pires Sanches JG, He Z, Ruegg L, You S, Yang W.   +6 more
europepmc   +1 more source

Hybrid Bacterial Colony Optimization and Particle Swarm Optimization for load balancing in fog computing. [PDF]

PLoS One
Kumar A, Gupta P, Verma R.
europepmc   +1 more source

Bioinspired Spatio-Temporal Cooperative Path Planning for Heterogeneous UAVs Driven by Bi-Level Games: An SSA-MPC Fusion Approach. [PDF]

Biomimetics (Basel)
Yu Y, Le M.
europepmc   +1 more source